Who Will Benefit From Swine Flu?
Since the swine flu pandemic began in early 2009, those who have benefited the most have been the businesses who have profited from selling related products and services. With many stock-pickers already pointing the way, the clearest beneficiaries will be in the health care sector and more specifically, pharmaceuticals. Those who invest in these companies now, alongside existing stakeholders, are likely to see continuing profit into 2010 with the forecasted escalation of the disease.
Image credit: Flickr
Amongst the companies who are benefiting the most from the outbreak is GlaxoSmithKline, the manufacturer of Ralenza the anti-flu drug. In Britain the pharmaceuticals giant has been accused of overcharging when it was discovered that the £6 drug Ralenza only cost them £1 to produce. So far it has earned them £300 million in the UK alone.
This company is also in the process of developing and manufacturing an anti swine flu vaccine. It already has orders for hundreds of millions of doses and is sure to become a huge money-spinner for the company. With countries such as United Arab Emirates starting to introduce mandatory magazines, the market for these products is likely to continue to grow.
On top of GSK, there is also Roche Holdings, the manufacturer of Tamiflu. Tamiflu has so far positioned itself as one of the most important drugs in the fight against swine flu. It is the most frequently prescribed anti swine flu drug in many countries, and its sales have gone through the roof (multiplying by 200%) this year as a result.
Outside of the pharmaceutical industry, many other healthcare businesses are making a large profit from swine flu. Amongst them is 3M, whose sales of regulation grade surgical masks for hospitals and members of the public are shooting up. Small businesses who stock the masks in various parts of Britain have reported selling out of the masks in the last few months as demand increases.
In fact, health-care related businesses in general are profiting from the crisis. Private hospitals and manufacturers of breathing machines have reported large gains as well as companies selling sanitising hand-wash, recommended for its role in preventing the spread of the disease. It is hard to underestimate the effects of a flu pandemic upon a health care business - panic has been widespread and even small companies have reported substantial gains.
Yet, there is one more type of person profiting from the swine flu outbreak, and that is the individual investor. Those who held stock in a healthcare corporation before the outbreak may have already cashed in with a massive return on their investment. Others are buying up now following the forecast that we will see a resurgence in swine flu towards the winter months.
I will withhold judgement as to whether profiting on the cure to a terrible disease is moral or immoral. However, suffice to say, this article demonstrates that a lot of people are becoming very rich as a result of the 2009 swine flu pandemic.
Image credit: Flickr
Amongst the companies who are benefiting the most from the outbreak is GlaxoSmithKline, the manufacturer of Ralenza the anti-flu drug. In Britain the pharmaceuticals giant has been accused of overcharging when it was discovered that the £6 drug Ralenza only cost them £1 to produce. So far it has earned them £300 million in the UK alone.
This company is also in the process of developing and manufacturing an anti swine flu vaccine. It already has orders for hundreds of millions of doses and is sure to become a huge money-spinner for the company. With countries such as United Arab Emirates starting to introduce mandatory magazines, the market for these products is likely to continue to grow.
On top of GSK, there is also Roche Holdings, the manufacturer of Tamiflu. Tamiflu has so far positioned itself as one of the most important drugs in the fight against swine flu. It is the most frequently prescribed anti swine flu drug in many countries, and its sales have gone through the roof (multiplying by 200%) this year as a result.
Outside of the pharmaceutical industry, many other healthcare businesses are making a large profit from swine flu. Amongst them is 3M, whose sales of regulation grade surgical masks for hospitals and members of the public are shooting up. Small businesses who stock the masks in various parts of Britain have reported selling out of the masks in the last few months as demand increases.
In fact, health-care related businesses in general are profiting from the crisis. Private hospitals and manufacturers of breathing machines have reported large gains as well as companies selling sanitising hand-wash, recommended for its role in preventing the spread of the disease. It is hard to underestimate the effects of a flu pandemic upon a health care business - panic has been widespread and even small companies have reported substantial gains.
Yet, there is one more type of person profiting from the swine flu outbreak, and that is the individual investor. Those who held stock in a healthcare corporation before the outbreak may have already cashed in with a massive return on their investment. Others are buying up now following the forecast that we will see a resurgence in swine flu towards the winter months.
I will withhold judgement as to whether profiting on the cure to a terrible disease is moral or immoral. However, suffice to say, this article demonstrates that a lot of people are becoming very rich as a result of the 2009 swine flu pandemic.
Labels: swine flu
posted by Admin at
08:19
0 Comments:
Post a Comment
<< Home